Weighted Average Number of Shares Outstanding, Diluted of Twist Bioscience Corp from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Twist Bioscience Corp quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • Twist Bioscience Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 59,808,000, a 3.1% increase year-over-year.
  • Twist Bioscience Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 59,808,000, a 3.1% increase from 2024.
  • Twist Bioscience Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 58,016,000, a 2% increase from 2023.
  • Twist Bioscience Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 56,885,000, a 5.6% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Twist Bioscience Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 59,808,000 +1,792,000 +3.1% 01 Jul 2025 30 Sep 2025 10-K 17 Nov 2025 2025 FY
Q2 2025 61,164,000 +3,019,000 +5.2% 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025 2025 Q3
Q1 2025 59,649,000 +1,870,000 +3.2% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025 2025 Q2
Q4 2024 59,162,000 +1,665,000 +2.9% 01 Oct 2024 31 Dec 2024 10-Q 03 Feb 2025 2025 Q1
Q3 2024 58,016,000 +1,131,000 +2% 01 Jul 2024 30 Sep 2024 10-K 17 Nov 2025 2025 FY
Q2 2024 58,145,000 +1,104,000 +1.9% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025 2025 Q3
Q1 2024 57,779,000 +1,002,000 +1.8% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025 2025 Q2
Q4 2023 57,497,000 +1,053,000 +1.9% 01 Oct 2023 31 Dec 2023 10-Q 03 Feb 2025 2025 Q1
Q3 2023 56,885,000 +3,000,000 +5.6% 01 Jul 2023 30 Sep 2023 10-K 17 Nov 2025 2025 FY
Q2 2023 57,041,000 +754,000 +1.3% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q3
Q1 2023 56,777,000 +3,305,000 +6.2% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q2
Q4 2022 56,444,000 +6,532,000 +13% 01 Oct 2022 31 Dec 2022 10-Q 02 Feb 2024 2024 Q1
Q3 2022 53,885,000 01 Jul 2022 30 Sep 2022 10-K 18 Nov 2024 2024 FY
Q2 2022 56,287,000 +7,324,000 +15% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q3
Q1 2022 53,472,000 +4,763,000 +9.8% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q2
Q4 2021 49,912,000 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023 2023 Q1
Q2 2021 48,963,000 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q3
Q1 2021 48,709,000 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q2

Twist Bioscience Corp Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 59,808,000 +1,792,000 +3.1% 01 Oct 2024 30 Sep 2025 10-K 17 Nov 2025 2025 FY
2024 58,016,000 +1,131,000 +2% 01 Oct 2023 30 Sep 2024 10-K 17 Nov 2025 2025 FY
2023 56,885,000 +3,000,000 +5.6% 01 Oct 2022 30 Sep 2023 10-K 17 Nov 2025 2025 FY
2022 53,885,000 +5,634,000 +12% 01 Oct 2021 30 Sep 2022 10-K 18 Nov 2024 2024 FY
2021 48,251,000 +9,061,000 +23% 01 Oct 2020 30 Sep 2021 10-K 21 Nov 2023 2023 FY
2020 39,190,000 01 Oct 2019 30 Sep 2020 10-K/A 05 Jun 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.